Precigen vs Scynexis
Scynexis is the larger business, with $20.6m of revenue in fiscal 2025 against $9.7m for Precigen (2.1 times as much). Scynexis grew faster (449.9% against 146.7%). Scynexis kept more of each dollar of sales as profit: a net margin of -41.8% against -2588.2%. Scynexis carries less debt relative to equity (0.0% against 478.2%).
| Latest fiscal year | PrecigenPGEN, 2025 | ScynexisSCYX, 2025 |
|---|---|---|
| Revenue | $9.7m | $20.6m |
| Revenue growth | 146.7% | 449.9% |
| Net income | −$251m | −$8.6m |
| Operating margin | -1141.1% | -78.0% |
| Net margin | -2588.2% | -41.8% |
| Return on equity | — | -16.5% |
| Free cash flow | −$89.8m | −$5.3m |
| Cash | $30.2m | $21.3m |
| Total debt | $100m | $0 |
| Debt to equity | 478.2% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 18 |
| Market value | $1.84bn | $39.1m |
| Price vs our value range | — | — |
| Moat score | 9 (Weak) | 9 (Weak) |
| Insider trades, 12 months | 1 buys, 40 sales | 1 buys, 0 sales |